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THE placenta, one of the most important fetal
tissues during gestation, ensures nutrition, devel-
opment and protection of the fetus. Although
placenta lacks expression of class II MHC
antigens, they can be induced either by inter-
feron-gamma (IFN-y) on the spongiotrophoblast
zone, or by 5-azacytidine (5-azaC) on the labyr-
inthine trophoblast zone, two agents actively par-
ticipating in a plethora of imInunological and
inflammatory reactions. This induction is corre-
lated with fetal abortion and fetal developmental
abnormalities. In this work the in vitro and in
vivo signal transduction pathways followed by
IFN-y or 5-azaC to induce class H antigen expres-
sion on placental cells by using specific pathway
inhibitors has been studied. It is shown that at
least three intracellular pathways are implicated
in the Ia induction, p21 is the first protein acti-
vated by the two agents while further signalling
requires Ca
2+ mobilization and PKC activations.
When the in vitro results are transferred to live
animals using the same inducing agents and
pathway inhibitors, it is found that theophylline
(Ca2+/CaM inhibitor) and anti-p21 are the most
potent suppressors of the IFN-y- and 5-azaC-
induced side effects during pregnancy. The data
presented here point to novel directions not only
as to the intracellular signalling, but also to the
use of pathway inhibitors in vivo to treat
aberrant antigen expression associated with fetal
loss.
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Introduction
Cellular crosstalk is the fundamental basis of
development, differentiation and survival of any
pluricellular organism. Protein binding to a cell
membrane receptor initiates intracellular signal-
ling reactions leading to the regulation of any
physiological process. The principal architecture
of the signal transduction pathways known up to
now, includes specific receptors, GTP-binding
proteins, second messenger generating protein
kinases, target functional proteins and regulatory
proteins.
This study is an analysis of the signal transduc-
tion pathway initiated by IFN-/leading to class II
major histocompatibility complex (MHC) antigen
expression on the adherent placental cells, which
previous studies have identified as spongio-
trophoblasts. IFN-,/ is known to induce class II
antigens in different human and murine cells and
tissues, including leukocytes, monocytes, glio-
blastomas and astrocytes.’-- However, the intra-
cellular pathway followed each time depends on
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the species and the cell tp+e studied. In humans,
IFNq, activates the Ca /Calmodulin (Ca2+/
CaM) pathway in most cases.5’s The second mes-
senger calcium ions bind to calmodulin, trigger-
ing conformational changes in this protein, and
allowing the activation of many enzymes, includ-
ing protein kinases. This Ca2+/CaM pathway
can be blocked by inhibitors like theophylline
and W7 (see the Methods section and Reference
5).
In the murine system, the induction of class II
antigens by IFNq, also involves the protein kinase
6 8 C (PKC) pathway.- Stimulation of receptors or
opening of Ca
2+ channels initiates hydrolysis of
phosphatidyl inositol (Ptdlns) by phospholipase
C where the subsequently produced diacylgly-
cerol (DAG) activates PKC, thus providing a
linkage between extracellular and intracellular
responses. Although DAG is the most important
stimulator of PKC, the latter can also be regu-
lated by other phospholipid derived messen-
gers. Upon activation of PKC, multiple positive
and negative regulatory signals may affect a pie-
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thora of target functional proteins. A way of abortion and in most cases (depending on the
studying the events occurring downstream of inhibitor used) lead the feto-placental develop-
PKC activation is by applying specific inhibitors, ment to physiological levels.
such as sphingosine and staurosporine.<8
Another important system shown in some Materials and Methods cases to be involved in class II antigen induction
by IFN-7 in humans as well as in mice, is the G- Mice: BALB/cJ and C3H/HeJ mice were main-
protein system.9’x2 It consists of a complicated tained in our Animal Breeding Unit at the Uni-
cascade of GTP-binding proteins located in the versity of Crete (Greece). Each BALB/cJ or C3H/
inner cell membrane, able to cross-link many cell HeJ female was individually caged with a BALB/cJ
surface receptors to effector proteins and initiate or C3H/HeJ male overnight and the following
many intracellular events, x2 This pathway was morning the females were examined for the pre-
approached by applying mevalonic acid lactone sence, of a vaginal plug. The morning where the
(MEV) to the cells which, although it does not plug was observed was considered as day zero of
have well defined properties,x’4 is employed as pregnancy.
a G-protein (ras) suppressor.
Study of the signal transduction mechanisms Pathway inhibitors: Theophylline (TPH) and W7
leading to class II antigen expression on murine (N-(6-aminohexyl)-5-chloro-l-napthalenesulfona-
trophoblasts are very important because these mide HCl) were used to block the Ca2+/CaM
cells directly regulate the feto-placental unit pathway.
5 TPH blocks the interaction between
development and control whether the outcome CaM and enzymes (inactive adenyl cyclase). This
of pregnancy is successful or not. Placental tro- drug is able to block the class II MHC antigen
phoblasts have been found not to express class induction by IFN-7 on the human cell lines HL-
II MHC antigens’5’6 and this negative state is 60, HeLa, U937, a Burkitt’s lymphoma, and Daudi
one of the protective mechanisms evoked by the cells.5 From the literature, dose-response experi-
fetus to escape maternal immune attack and ments place the best working concentration at
avoid autoimmune reactions. It has been shown 0.15 mg/ml. For this work and cellular system
previously in mice that the two trophoblast layers (the trophoblast portion of adherent placental
of the placenta differ in their inducibility to cells), doses of 0.2 and 0.1mg/ml (Sigma, St
express class II antigens. Spongiotrophoblast Louis, MO) were applied. The higher dose
derived trophoblasts are found to be under regu- (0.2 mg/ml) gave the best results as to the reduc-
latory control and are susceptible to induction of tion of class II MHC antigen expression by IFN-7
class II antigens by IFN-7 in vitro and in and 5-azaC. W7 is a CaM antagonist that binds
ViVO.8’17’18 Trophoblasts in the inner placental CaM and inhibits calcium ion-CaM regulated
layer (labyrinthine trophoblast zone)can only be activities. In the cellular systems used by Ina et
induced to express these antigens upon stimula- aL 5, dose-response experiments (10, 20, 30btM)
tion with the demethylating agent 5-azaC in vitro showed that the best working conditions are
as well as in vivo.8’9 In both systems studied, obtained with 10 and 20 l.tM of W7. For the
class II antigen induction is preceded by the acti- present system, W7 (Sigma) was used in vitro at
vation of p21ras.
2 the concentration of 15 l.tM, which gave the best
In the present communication, a possible responses.
signal transduction pathway is proposed, trig- Sphingosine (SPH) and staurosporine (St) are
gered by IFN-7 and 5-azaC leading to class II potent inhibitors of the PKC pathway, which are
antigen and p21
ras expression on placental known to inhibit the activity of PKC. SPH has
adherent cells. It is shown that class II antigen been used in several cell lines to block the class
induction by both agents requires activation of II antigen induction by IFN-7, including human
Cai+/CaM, PKC and p21r Intracellular signal- THP-1, murine WEHI-3, bone marrow macro-
ling begins with p21
ras activation since only MEV phages, where dose-response experiments (1,
inhibits induction of p21
ras and class II antigen 10, 50tM) have shown that 501.tM offers
68 expression. This step is followed by Ca2+/CaM maximal inhibition.’ In the present work 50btM
and PKC activation, whereas the pathway of tyro- and 25 btM of SPH (Sigma) were applied to the
sine kinase (TK) is not involved in this process, adherent placental cells and it was found that the
The importance of these results lies in in vivo best reduction of class II antigen expression
experiments where an attempt was made to induced by IFN-7 and 5-azaC is obtained at the
reverse the IFN-7- and 5-azaC-induced harmful concentration of 501M (151g/ml). St inhibits the
effects by injecting the treated pregnant mice phospholipid calcium ion dependent protein
with specific pathway inhibitors. The results kinase C. This product was purchased from UBI
show that appropriate treatments can rescue fetal (Lake Placid, NY) and showed the best inhibitory
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effect on the induction of class II antigen expres-
sion by IFN-7 and 5-azaC at the concentration of
50nM, which is in agreement with the dose-
res_.ponse experiments performed by Gumina et
a12
Mevalonic acid (MEV) is an intermediate
product in cholesterol synthesis and it is claimed
to interfere with the G protein pathway through
HMG-CoA and farnesylation of cysteins.
12 MEV
was purchased from Sigma and tested at the con-
centrations of 5mM (0.65 mg/ml) and 50mM
(6.5 mg/ml). Since both concentrations effectively
inhibited class II and p21
ras expression induced
by IFN-7 and 5-azaC with no apparent toxic
effects, the lowest concentration was used.
Genistein (Gen, 4’,5,7-trihydroxyisoflavone), a
potent inhibitor of tyrosine-specific protein
kinase (TK)9, was purchased from UBI and
tested at concentrations of 10, 30 and 50 l.tg/ml.
None of these concentrations was able to block
the class II or p21
ras antigen expression induced
by IFN-7 and 5-azaC. However, this drug when
applied to a tyrosine kinase dependent system
(T98G human glioblastoma) shows its inhibitory
activity even at the dose of 10 l.tg/ml.
Antibodies: Rat anti-p21
ra neutralizing mono-
clonal antibody (Ab-1, Oncogene Sc. Inc. Man-
d k d hasset, NY), mouse anti-IA or IA or K or K
k
monoclonal antibodies (Becton Dickinson,
Meshelen, Belgium), mouse monoclonal anti-
cytokeratin antibody (PKK1, Labsystems, Helsinki,
Finland), mouse monoclonal anti-vimentin anti-
body (PK-V, Labsystems) and rat anti-mouse Mac-
1 antibody (Caltag Lab, San Francisco, CA) were
used at a concentration of 1 l.tg/ml for in vitro
detection of the equivalent proteins. Anti-mouse
or anti-rat IgG coupled to FITC antibodies
(Sigma) were used at a dilution of 1/100 and
1/150, respectively. Mouse IgG or rat IgG were
used as negative controls to the above antibodies.
Placental cell cultures: Placental cell cultures
were performed as described previously
2 with
slight modifications. Briefly, placentae were iso-
lated from BALB/cJ x BAIJ3/cJ or BAI./cJ x
C3H/HeJ pregnant mice on day 11 to 14 of
gestation and, after removing the maternally
derived decidual cap layer, the tissue was cut into
small pieces and single cell suspensions were
prepared by passing the preparation through a
syringe with a 181/2G needle, into Hank’s solu-
tion.’The cells were washed three times and cul-
tured at the concentration of 1 x 106 cells/ml in
RPMI 1640 medium supplemented with 10% fetal
calf serum (FCS, Seralab, Sussex, England) in
35mm Falcon plates (Becton Dickinson, Oxnard,
CA). On the fourth day of culture the cells were
washed to eliminate the non-adherent cells and
growth factor containing medium, which was
then replaced with fresh RPMI 10% FCS medium,
and the next day IFN-7 (100 U/ml, Holland Bio-
technology, Leiden, The Netherlands) or 5-azaC
(2 l.tM, Sigma) with or without the various inhibi-
tors were added to the cells. All cultures were
incubated at 37C, 5% CO2 until the seventh day
of culture, where marker analysis experiments by
the immunofluorescence technique were per-
formed on the adherent layer of cells.
In vivo treatment ofpregnant females: BALB/cJ
females pregnant with BAI/cJ males were injec-
ted intraperitoneally from day 6 to 11 of gesta-
tion with 5 000U recombinant IFN-7 (0.5/.tg/
mouse) per day, or 5-azaC (10btg/injection), or
phosphate buffered solution (PBS, Gibco, Grand
Island, NY). The IFN-7- or 5-azaC-treated animals
were additionally injected with the TPH and SPH
pathway inhibitors or antibodies to p21
ras and
class II antigens. TPH was administered i.p. at the
dose of 0.15mg/injection to pregnant mice on
days 6 and 10 of gestation, whereas SPH was
given i.p. at the dose of 15 l.tg/injection on days
6, 8 and 10 of pregnancy. These doses were
determined from preliminary experiments by
injecting various doses of TPH and SPH from day
6 to 11 of gestation. Once the lowest effective
dose was estimated, the time intervals between
the injections was increased to finally determine
the doses described above. The neutralizing anti-
class II antibody was injected i.v. at a dose of
50btg/injection on days 8 and 10 of pregnancy.
The neutralizing anti-p21
r was injected in vivo
i.p. into pregnant mice at the concentration of
5 l.tg/injection on days 6, 7, 9 and 10 of gestation.
Higher doses of this antibody given i.v. or i.p. at
longer time intervals (20-30 btg on days 8, 10 or
11) significantly affected fetal viability (data not
shown). On the 12th day of gestation the animals
were killed by cervical dislocation and fetal
resorptions were evaluated. Placentae and fetuses
were isolated and weighed using a high precision
balance (Sartorius 2434).
Indirect immunofluorescence: Immuno-
fluorescent staining was performed as described
previously. Briefly, adherent placental cells were
lifted from the culture plates using cell scrapers,
washed with PBS supplemented with 0.2%
bovine serum albumin (BSA, Sigma) and 0.01%
sodium azide (Sigma, PBS-BSA-azide) and
placed in 96-well V-bottomed plates at a con-
centration of 1 x 106 cells/well. For cytoplasmic
protein detection, the cells were permeabilized
with ice-cold methanol (20% for 20 min at 4C).
Following this step (where necessary) the cells
Mediators of Inflammation Vol 4 1995 211I. Athanassakis
Ca2+ICaM Pathway
G-protein Pathway
PKC Pathway
Oi __.
1
20
TK Pathway
FIG. 1. Net modification of IFN--induced class II antigen expres-
sion on adherent placental cells by different pathway inhibitorso
Primary adherent placental cells were treated on day 5 with IFN-
/ _+ inhibitors and tested for class II antigen expression (using
monoclonal anti-lA
d or anti-lA antibodies) on the seventh day by
immunofluorescence (see Methods). TPH (theophylline) and W7
were used as inhibitors for the Ca2+/CaM pathway, SPH (sphin-
gosine) and St (staurosporine) as inhibitors for the PKC pathway,
Mev (mevalonic acid) for the G-protein pathway and Gen (genis-
tein) for the TK pathway (n=5). Doses are given in Methods.
Vertical lines represent the standard deviation (SD) of triplicate
counts.
Note 1." Net values represent the subtracted difference between
the specific antibody reacted cells and negative control, which
did not exceed 10%.
Note 2: The experiments in this study were conducted on
unfractionated adherent placental cells, having the following
characteristics: cytokeratin, 64_+ 1%; vimentin, 2 _+ 1%; Mac-l,
65 _+ 1%; class I, 65 +_ 1%; class II, 3 _+ 1%, as assessed by immu-
nofluorescence staining.
were reacted first with 1% normal goat serum,
then with the test antibody and finally with a
FITC conjugated anti-mouse or anti-rat antibody.
All incubations were performed at 4C for 30
min. Extensive washing followed each step of the
procedure. The cells were immobilized with 25%
glycerol, mounted on slides and fluorescence
intensity was evaluated using a Zeiss (Oberko-
chen, Germany) fluorescence microscope. Cells
with weak or no staining were scored as nega-
tive. Positive cells were considered as those
showing bright to very bright fluorescence inten-
sity. The results concerning p21
ras and class II
MHC antigen regulation (shown in the figures)
are expressed as the net percentage of fluor-
escent cells (test group negative control
group), + standard deviation.
Statistical analysis: In all experiments, Student’s
t-test was used for the evaluation of significance
levels (p). All other statistical values show the
mean + standard deviation (S.D.).
Results
In vitro study of signal transduction pathways
leading to class II andp2I
ras expression by IFN-
2: Previous studies have shown that IFN-2 is a
potent inducer of class II MHC antigens on the
spongiotrophoblasts. In this work, the intracel-
lular pathways stimulated by IFN-7, leading to
class II antigen expression are analysed, and the
involvement of four different pathways, Ca2+!/
CaM, PKC, G-proteins and TK, is tested. Primary
placental cells were prepared as described in the
Methods section and on the fifth day of culture
these were stimulated with IFN-7 and various
inhibitors. The presence of TPH or W7 in these
IFN-7-stimulated placental cell cultures resulted in
a 85 and 50% (p < 0.001 and p < 0.005) reduc-
tion of class II antigen expression, respectively,
as tested by immunofluorescence (Fig. I(A)).
Although both inhibitors block the Cai+/CaM
pathway, their action is localized at different
levels (see Methods), which may explain the dif-
ference in the degree of inhibition. These results
indicate that class II antigen induction by IFN-/
requires mobilization of Ca
2+ (see Discussion).
In order to assess intracellular cross-talk with
other pathways, placental cell cultures were
treated with SPH and staurosporine, two potent
inhibitors of PKC activation. These agents caused
82 and 71% inhibition (p< 0.001) of class II
expression, respectively, as compared with IFN-7-
induced cells (Fig. I(B)). Thus, PKC is also
involved in the IFN-7 signal transduction pathway
leading to class II antigen expression.
It has been previously reported that the
expression of p21
ras is stimulated in the IFN-2-
treated trophoblast cells.
2 In order to further
test whether intracellular cross-talk with the G-
protein pathway is necessary to IFN-7-induced
class II antigen expression, MEV was applied to
the adherent placental cells. The application of
this agent completely suppressed class II antigen
induction, giving only background staining of the
cells (Fig. 1(C)). MEV was unable to suppress
IFN-7-induced expression of class II antigens on
human HL-60 and HeLa cells as well as murine
WEHI-3 and 70Z cell lines (data not shown).
Finally, the involvement of TK in ,his system was
excluded, since application of genistein to the
cultures did not have any effect on class II
antigen expression (Fig. I(D)).
Following the same reasoning and experi-
mental protocols, the signal transduction pathway
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riced and the weight of placenta, ferns and
maternal spleen as well as the percentage of fetal
abortion was recorded: TPH and SPH, when
administered during the IFN-( treatment, reduce
fetal abortion to normal levels, whereas IFN-g
treatment alone increases the percentage of fetal
loss 3-fold, as compared with untreated controls
(Table 1). However, only TPH significantly, but
not completely, corrects the effect of IFN-/ in
fetal and spleen weight (Table 1). Thus, TPH
causes an 88% increase in fetal weight
(p< 0.001), and a 46% reduction in spleen
weight (p< 0.005), as compared with IFN-g
treatment alone. SPH gives a 38% reduction
(p < 0.005) in spleen weight but it does not sig-
nificantl increase fetal size (Table 1). Placental
weight is not affected in either case. While testing
the toxicity of TPH and SPH during pregnancy,
control experiments show that the doses used
do not affect fetal viability or maternal spleen
weight, but reduce fetal weight non-significantly.
It was then attempted to confirm, in an addi-
tional way, the above described results by inject-
FIG. 2. Net modification of IFN-(-induced p21 expression on ing the IFN-2-treated pregnant mice with
adherent placental cells by different pathway inhibitors. Primary neutralizing monoclonal antibodies against p21
ras
adherent placental cells were treated on day 5 with IFN-, + inhi-
bitors and tested for p21 expression on the seventh day by and class II antigenic determinants. The combi-
immunofluorescence (n=5, see Methods, and legend to Fig. 1). nation of IFN-( + anti-p21
ras gives a 51% and
Vertical lines represent the standard deviation (S.D.) of triplicate 123% increase in placental and fetal weight
counts. Net values and cell characterization are as given in respectively, as compared with the IFN-’ treat- Fig. 1.
ment alone. Spleen weight is reduced by 41%
(p< 0.005), whereas the percentage of fetal
leading to p21s antigen expression after IFNq, abortion returns to physiological levels (Table 1).
administration was studied. The results show that The combination IFNq, + anti-Ia reduced fetal
only mevalonic acid lactone completely ablated abortion to normal levels and increased placental
p21
ras expression, whereas all the other inhibi- and fetal weight by 43% and 100% respectively,
tors did not significantly affect this expression as compared with IFNq,-treated pregnant mice.
(Fig. 2). These results indicate that p21
ras is an However, this treatment did not significantly
intermediate product to the class II antigen reduce the maternal spleen weight (Table 1, see
induction by IFN-% and its activation precedes Discussion).
the Ca
2+ mobilization and PKC activation.
In vitro and in vivo study of signal transduction
In vivo study of signal transduction pathways pathways leading to class II and p21
ras expres-
leading to class II andp2I
ras expression by IFN- sion by 5-azaC: It is known that the demethylat-
2: It has been shown previously by this labora- ing agent 5-azaC induces class II and p21
ras
tory that administration of IFNq, to pregnant antigen expression on trophoblasts derived from
mice from day 6 to 11 of gestation increases fetal the labyrinthine trophoblast zone of the pla-
abortion, reduces fetal size and, among other centa.1’2 It is shown that class II antigen expres-
dysfunctions obseeeed at the maternal level, it sion is affected by the same inhibitors as for the
increases the size of the spleen approximately’3- IFNq,-induced expression of these antigens.
fold. These IFNq,-induced events were asso- Specifically, TPH and W7 reduce the 5-azaC-
ciated with the expression of class II MHC anti- included class II antigen expression by 54% and
gens as well as the p21
a protein on the 38% respectively (p< 0.005), as compared with
spongiotrophoblast layer of the placenta. 5-azaC treated cells (Fig. 3(A)). Furthermore,
In order to test whether the in vitro results SPH and St inhibit the expression of these anti-
described above can also be applied in vivo, gens by 75% and 97% (p< 0.001) respectively
pregnant mice were injected with IFN-, and inhi- (Fig. 3(B)), whereas the application of MEV gives
bitors (doses and timing given in Methods). On 100% inhibition of Ia antigen expression
the I2th day of pregnancy, the mice were sacri- (Fig. 3(C)). The TK pathway does not seem to
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Table 1. Protection of fetal development from IFN-y-induced side effects by specific pathway inhibitors in vivo
Treatment* Weight (mg +/- S.D.) Fetal resorption
Placenta** Fetus** Spleen % n
94_+ 6 159 +/- 8 118 +/- 16 18 +/- 3 10
IFN-y 61 +/- 6 43 + 12 315 +/- 20 54 +/- 8 20
IFN-y+TPH 85_+ 9 81 +/- 9 169 +/- 32 15_+ 8
IFN-7 + SPH 70 +/- 4 57 +/- 4 194 +/- 2 15 +/- 5 8
IFN-y+anti-p21ras 92 + 5 96 +/- 11 185 +/- 10 17 +_ 5 10
IFN-y + anti-class II 87 +/- 9 86 _+ 4 274 +/- 21 15 +/- 5 15
TPH 67 +/- 9 64 +/- 2 102 +/- 20 25 +/- 7 5
SPH 78 +/- 15 72 +/- 11 115 +/- 16 15 +/- 5 5
anti-p21 89 _+ 5 99 +_ 8 180 +/- 10 0 8
anti-classll 91 +/- 17 109 +/- 9 124 +/- 15 7 +/- 3 8
*Pregnant mice were treated as described in Methods. Briefly, IFN-7 (5 000 U/injection) was administered i.p. to the animals from day
6 to 11 of gestation. TPH (0.15 mg/injection) was given i.p. either alone or with IFN-7 on days 6 and 10 of pregnancy. SPH (15 Ig/
injection) was given i.p., alone or with IFN-y on days 6, 8 and 10 of pregnancy. Anti-p21 (51g/injection) was administered i.p.,
either alone or with IFN-y on days 6, 7, 9 and 10 of gestation. Finally, anti-class II monoclonal antibody (anti-lAd, 50 Ig/injection) was
administered i.v., either alone or with IFN-y on days 8 and 10 of gestation, p values are given in the text.
**Resorbed sites were not included in the means.
Ca2+ICaM Pathway PKC Pathway
--
G-protein Pathway TK Pathway
CaZ+ICaM Pathway
G-protein Pathway
PKC Pathway
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FIG. 3. Net modification of 5-azaC-induced class II antigen
expression on adherent placental cells by different pathway inhi-
bitors. Primary adherent placental cells were treated on day 5
with 5-azaC + inhibitors and tested for class II antigen expres-
sion (using monoclonal anti-lA
d or anti-lA antibodies) on the
seventh day by immunofluorescence (n=5, see Methods and
legend to Fig. 1). Vertical lines represent the standard deviation
(S.D.) of triplicate counts. Net values and cell characterization
are as given in Fig. 1.
FIG. 4. Net modification of 5-azaC-induced p21 expression on
adherent placental cells by different pathway inhibitors. Primary
adherent placental cells were treated on day 5 with 5-azaC +/-
inhibitors tested for p21 expression on the seventh day by
immunofluorescence (n=5, see Methods and legend to Fig. 1).
Vertical lines represent the standard deviation (S.D.) of triplicate
counts. Net values and cell characterization are as given in
Fig. 1.
be involved in this system, since genistein does
not affect the 5-azaC-induced expression of these
antigens on placental cells (Fig. 3(D)). All these
inhibitors were used at the same doses as those
described for IFN-(.
Application of these inhibitors in order to
examine changes at the p21
ras expression levels,
showed that only MEV could block the appear-
ance of the p21
ra= proteins (Fig. 4). Administra-
tion of 101.tg of 5-azaC to pregnant mice i.p.
from days 6 to 11 of gestation, results either in
complete fetal abortion or in very high percen-
tages of fetal loss, where the surviving embryos
9 ed (10 15%) have abnormal development. Bas
on the in vitro results described above, the
reversal of 5-azaC-induced events by TPH or
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Table 2. Protection of fetal development from 5-azaC-induced side effects by specific pathway inhibitors in vivo
Treatment* Weight (mg + S.D.) Fetal resorption
Placenta** Fetus** % n
94 +/- 6 159 +/- 8 18 + 3 10
5-azaC 52 +/- 10 105 +/- 18 (100) 20
5-azaC+TPH 92 + 15 97 +/- 11 39 +/- 5 8
5-azaC+SPH 74 +/- 6 90 +/- 4 21 +/- 9 8
5-azaC + anti-p21 78 +/- 12 88 +/- 8 16 +/- 4 12
5-azaC + anti-class II 80 +/- 7 115 +/- 9 0 15
TPH 67 +/- 9 64 +/- 2 25 +/- 7 5
SPH 78 +/- 15 72 +/- 11 15 +/- 5 5
anti-p21 89 +/- 5 99 +/- 8 0 8
anti-class II 91 +/- 17 109 +/- 9 7 +/- 3 8
*Pregnant mice were treated as described in Methods. Briefly, 5-azaC (10 lg/injection) was administered i.p. to the animals from day 6
to 11 of gestation. TPH (0.15 mg/injection) was given i.p., either alone or with 5-azaC on days 6 and 10 of pregnancy. SPH (15 Ig/
injection) was given i.p., either alone or with 5-azaC on days 6, 8 and 10 of pregnancy. Anti-p21 (5 Ig/injection) was administered
i.p., either alone or with 5-azaC on days 6, 7, 9 and 10 of gestation. Finally, anti-class II monoclonal antibody (anti-lAd, 50 lg/injection)
was administered i.v., either alone or with 5-azaC on days 8 and 10 of gestation, p values are given in the text.
**Resorbed sites were not included in the means.
SPH, or anti-p21
ras or anti-class II monoclonal
antibodies, was attempted. All treatments rescued
fetal abortion induced by 5-azaC alone and
increased placental size to normal (Table 2).
Fetal size was not significantly different from that
in the untreated animals and spleen weight was
not affected in any case (data not shown).
Discussion
When a physiological or chemical agent comes
in contact with the surface of a cell, second mes-
senger signals are transmitted not only to down-
stream functional proteins, but also to upstream
compounds and members of other signal trans-
duction pathways in order to give this cell spe-
cific instructions about its function(s) and
phenotype. The major event studied here is the
induction of class II MHC antigens by IFN-, on
the placenta. Although the mechanisms of induc-
tion of these antigens by IFN-, have been exam-
ined in many systems, including different cell
types of different species, my interest in tropho-
blasts comes from the biological significance of
this mechanism and the role it may play in escap-
ing fetal abortion and ameliorating conditions of
fetal survival. The results show that at least three
pathways are involved in the signal transduction
mechanism of class II antigen expression on
2+ trophoblasts, including Ca mobilization, PKC
and p21
ras activation. In cases such as pregnancy,
graft implantation and autoimmune disorders, the
expression of class II antigens has harmful effects
on the organism and such activation has to be
depressed. This is in contrast with systems
studied by other investigators, where MHC class
II induction benefits the organism by stimulating
the immune system. Thus, after using adherent
placental cells, the in vitro findings concerning
inhibition of class II antigens via the three de-
scribed pathways were transferred to in vivo
experiments. It was shown that the inhibitors
which block the induction of these antigens
protect the fetus from abortion and ameliorate
the conditions of fetal development.
In this study specific inhibitors of four differ-
ent pathways were employed: TPH and W7 to
suppress the Cai+/CaM system; SPH and stauro-
sporine to inhibit PKC activation; mevalonic acid
to block G-proteins (ras); and genistein to
inhibit the TK system. All but genistein were able
to block class II antigen expression induced by
IFN-T, on adherent placental cells.
It has been shown previously that the induc-
tion of class II antigens on trophoblasts is closely
linked to the cellular ras oncogene, which was
also found to be stimulated by the IFN-, treat-
ment on the same cells,i Using mevalonic acid
lactone as an inhibitor of p21 ras, and conse-
quently of G-proteins, it was possible to block
the class II antigen induction by IFN-T. Results
indicated that p21
ras activation occurs upstream
to the stimulation of class II antigens.
In order to place p21
rs activation within the
signal transduction pathway of IFN-T and/or
examine possible degrees of intracellular cross-
talk, the inhibitors to Cai+/CaM, PKC and TK
were tested for their ability to block the expres-
sion of p21 rs. With the exception of mevalonate,
none of the inhibitors was able to inhibit such
induction, indicating that p21
ras activation is the
first step in the signal transduction pathway
leading to class II antigen expression.
It has been reported from this and other
laboratories that administration of IFN-, to preg-
nant mice affects feto-placental development as
well as maternal physiology.18’2’22 In view of the
present in vitro results, I attempted to block the
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in vivo IFNq,-induced side effects by specific
pathway inhibitors (TPH and SPH), anti-class II
or anti-p21
ras antibodies. All these treatments
rescued the IFN-,-induced abortion, TPH and
anti-p21
ras being the most efficient.
In the last section of this work, I concentrated
on the mechanisms inducing class II antigen
expression on the labyrinthine trophoblast after
5-azaC treatment. It is demonstrated that the
same inhibitors blocking the IFN-’f-induced class
II and p21
as expression, also inhibit the 5-azaC-
induced stimulation, both in vitro and in vivo.
It is thus proposed that the sequence of events
leading to class II expression and ultimately fetal
rejection after IFN-7 or 5-azaC administration
begins with an initial p21
ras activation followed
by either Ca
2+ mobilization and PKC activation
or vice versa. This does not exclude the possibi-
lity that the two agents may follow or share other
means of propagating their signals leading,
however, to the same endpoint. In vivo applica-
tion of pathway inhibitors is able to reverse the
side effects not only at the feto-placental but
also the maternal level. It is premature to spec-
ulate that the use of TPH, anti-p21 ras SPH and to
a lesser degree anti-class II antibodies, can be
used as therapeutic agents. However, further
experimentation may prove that administration of
these or analogue reagents may have a potential
role in the future. It is clear that aberrant expres-
sion of class II antigens on the murine placenta
lead to fetal rejection.’8’2 These findings can be
generalized to the role of IFNq,-mediated class II
upregulation in the induction of immune respon-
ses, graft rejection or autoimmune diseases.
Although in the present study the class II indu-
cers were given exogenously, multiple mechan-
isms including viral or microbial infection,
cytokine overproduction, and hormonal dis-
equilibrium, may lead to the production of IFN-/
and/or other inflammatory cytokines with syner-
gistic potential like TNFz, IL-6, IL-1 and IL-12. All
possibilities are valid until definitive proof can be
provided, a task that is being undertaken at this
laboratory.
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